Shenzhen Lifotronic Technology Co (688389) - Total Liabilities

Latest as of March 2026: CN¥382.72 Million CNY ≈ $56.00 Million USD

Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has total liabilities worth CN¥382.72 Million CNY (≈ $56.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shenzhen Lifotronic Technology Co liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Shenzhen Lifotronic Technology Co - Total Liabilities Trend (2016–2025)

This chart illustrates how Shenzhen Lifotronic Technology Co's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shenzhen Lifotronic Technology Co balance sheet assets.

Shenzhen Lifotronic Technology Co Competitors by Total Liabilities

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their total liabilities.

Company	Country	Total Liabilities
Dakota Gold Corp. NYSE MKT:DC	USA	$3.34 Million
Argus Shanghai Textile Chemicals Co Ltd SHG:603790	China	CN¥423.14 Million
Peoples Fin NASDAQ:PFIS	USA	$4.90 Billion
Beijing WKW Automotive Parts Co Ltd SHE:002662	China	CN¥1.47 Billion
Ruitai Materials Technology Co Ltd SHE:002066	China	CN¥3.60 Billion
Tronox Holdings PLC NYSE:TROX	USA	$4.77 Billion
Jaya Sukses Makmur Sentosa Tbk PT JK:RISE	Indonesia	Rp747.45 Billion
Shenzhen Sunwin Intelligent SHE:300044	China	CN¥1.03 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Shenzhen Lifotronic Technology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Shenzhen Lifotronic Technology Co to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Lifotronic Technology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Lifotronic Technology Co (2016–2025)

The table below shows the annual total liabilities of Shenzhen Lifotronic Technology Co from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥700.79 Million ≈ $102.55 Million	-17.08%
2024-12-31	CN¥845.13 Million ≈ $123.67 Million	+58.34%
2023-12-31	CN¥533.76 Million ≈ $78.11 Million	+41.57%
2022-12-31	CN¥377.02 Million ≈ $55.17 Million	+74.14%
2021-12-31	CN¥216.50 Million ≈ $31.68 Million	+48.31%
2020-12-31	CN¥145.98 Million ≈ $21.36 Million	+12.91%
2019-12-31	CN¥129.29 Million ≈ $18.92 Million	-9.92%
2018-12-31	CN¥143.53 Million ≈ $21.00 Million	+16.56%
2017-12-31	CN¥123.15 Million ≈ $18.02 Million	-2.80%
2016-12-31	CN¥126.69 Million ≈ $18.54 Million	--

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices

Market Cap

$697.86 Million

CN¥4.77 Billion CNY

Market Cap Rank

#10731 Global

#2961 in China

Share Price

CN¥11.13

Change (1 day)

+1.09%

52-Week Range

CN¥9.59 - CN¥14.74

All Time High

CN¥37.22